STRUCTURAL BASIS OF CA2+-CALMODULIN-CALCINEURIN SIGNALLING

CA2-钙调蛋白-钙调磷酸酶信号传导的结构基础

基本信息

  • 批准号:
    7955144
  • 负责人:
  • 金额:
    $ 0.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. None of this research is specifically directed to AIDS, but the studies are directed toward understanding the protein-protein interactions underlying T cell activation. There is also published evidence that the Ca2+-calmodulin-calcineurin pathway contributes to reactivation of Kaposi sarcoma-associated herpesvirus in latently infected cells. The overall goal of this subproject is to obtain detailed structural and kinetic information on signalling in the Ca2+-calmodulin-calcineurin pathway. Calcineurin (CN) is activated either locally by Ca2+ signals in cellular microdomains or globally by widespread cytoplasmic Ca2+ signals, and controls the activity of other cellular proteins by dephosphorylating specific phosphoserine or phosphothreonine residues. CN has a prominent role in T cells, where it regulates the transcription factor NFAT and thereby the transcription of cytokine genes and other genes associated with T cell activation. This role of CN is the target of the clinical immunosuppressive drugs cyclosporin A and tacrolimus. CN is also implicated in developmental processes, including the proper formation of cardiac valves and the vascular system, and in pathophysiological changes, including myocardial hypertrophy and vascular restenosis after injury. This project addresses (1) how CN signalling is directed through recognition of individual CN substrates; (2) how CN signalling is directed through interaction with targeting and regulatory proteins; (3) the conformational changes that initiate and sustain CN activation; and (4) the kinetics of the conformational changes and protein-protein interactions that translate cytoplasmic Ca signals into CN signalling.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 这些研究都不是专门针对艾滋病的,但这些研究旨在了解T细胞活化背后的蛋白质-蛋白质相互作用。 也有发表的证据表明,Ca 2 +-钙调蛋白-钙调磷酸酶途径有助于在潜伏感染细胞中重新激活卡波西肉瘤相关疱疹病毒。 这个子项目的总体目标是获得详细的结构和动力学信息的信号在钙离子-钙调蛋白-钙调磷酸酶途径。 钙调神经磷酸酶(CN)通过细胞微区的Ca 2+信号局部激活或通过广泛的细胞质Ca 2+信号全局激活,并通过使特定的磷酸丝氨酸或磷酸苏氨酸残基去磷酸化来控制其他细胞蛋白的活性。 CN在T细胞中具有突出的作用,其中它调节转录因子NFAT,从而调节细胞因子基因和与T细胞活化相关的其他基因的转录。 CN的这种作用是临床免疫抑制药物环孢素A和他克莫司的靶点。 CN还涉及发育过程,包括心脏瓣膜和血管系统的正确形成,以及病理生理变化,包括心肌肥大和损伤后血管再狭窄。 该项目涉及 (1)如何通过识别单个CN底物来引导CN信号传导; (2)如何通过与靶向和调节蛋白的相互作用来引导CN信号传导; (3)引发和维持CN活化的构象变化;以及 (4)构象变化和蛋白质-蛋白质相互作用的动力学,将细胞质Ca信号转化为CN信号。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anjana Rao其他文献

Anjana Rao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anjana Rao', 18)}}的其他基金

Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10441261
  • 财政年份:
    2020
  • 资助金额:
    $ 0.13万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10819075
  • 财政年份:
    2020
  • 资助金额:
    $ 0.13万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10202515
  • 财政年份:
    2020
  • 资助金额:
    $ 0.13万
  • 项目类别:
Exploring the potential of TET inhibition in cancer immunotherapy
探索 TET 抑制在癌症免疫治疗中的潜力
  • 批准号:
    10665608
  • 财政年份:
    2020
  • 资助金额:
    $ 0.13万
  • 项目类别:
Epigenetic control of Foxp3 expression in induced T regulatory cells
诱导 T 调节细胞中 Foxp3 表达的表观遗传控制
  • 批准号:
    10166759
  • 财政年份:
    2017
  • 资助金额:
    $ 0.13万
  • 项目类别:
Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
  • 批准号:
    10522926
  • 财政年份:
    2017
  • 资助金额:
    $ 0.13万
  • 项目类别:
Investigating the role of TET deficiency in promoting T cell expansion and inflammation
研究 TET 缺陷在促进 T 细胞扩增和炎症中的作用
  • 批准号:
    10640187
  • 财政年份:
    2017
  • 资助金额:
    $ 0.13万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    10477020
  • 财政年份:
    2016
  • 资助金额:
    $ 0.13万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    9978730
  • 财政年份:
    2016
  • 资助金额:
    $ 0.13万
  • 项目类别:
TET enzymes as guardians of genome stability
TET 酶作为基因组稳定性的守护者
  • 批准号:
    9342700
  • 财政年份:
    2016
  • 资助金额:
    $ 0.13万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.13万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了